Sfoglia per Autore
Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma
2003-01-01 Sanguineti, G.; Bossi, P.; Pou, A.; Licitra, L.
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1]
2003-01-01 Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L.
Head and neck cancer
2004-01-01 Licitra, L.; Locati, L. D.; Bossi, P.
Head and neck tumors other than squamous cell carcinoma
2004-01-01 Licitra, L.; Locati, L. D.; Bossi, P.; Cantu, G.
Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy
2004-01-01 Palazzi, M.; Guzzo, M.; Bossi, P.; Tomatis, S.; Cerrotta, A.; Cantu, G.; Locati, L. D.; Licitra, L.
Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma
2004-01-01 Licitra, L.; Suardi, S.; Bossi, P.; Locati, L. D.; Mariani, L.; Quattrone, P.; Lo Vullo, S.; Oggionni, M.; Olmi, P.; Cantu, G.; Pierotti, M. A.; Pilotti, S.
Herceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancer [1]
2005-01-01 Locati, L. D.; Rinaldi, G.; Bossi, P.; Dagrada, G. P.; Quattrone, P.; Cantu, G.; Licitra, L.
Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas?
2005-01-01 Bergamini, C.; Barisella, M.; Locati, L. D.; Bossi, P.; Potepan, P.; Rinaldi, G.; Licitra, L.
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15]
2005-01-01 Licitra, L.; Bossi, P.; Locati, L. D.; Bergamini, C.
Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland
2005-01-01 Locati, L. D.; Guzzo, M.; Bossi, P.; Massone, P. P. B.; Conti, B.; Fumagalli, E.; Bareggi, C.; Cantu, G.; Licitra, L.
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
2006-01-01 Licitra, L; Perrone, F; Bossi, P; Suardi, S; Mariani, L; Artusi, R; Oggionni, M; Rossini, C; Cantu, G; Squadrelli, M; Quattrone, P; Locati, Ld; Bergamini, C; Olmi, P; Pierotti, Ma; Pilotti, S
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma
2006-01-01 Perrone, F.; Suardi, S.; Pastore, E.; Casieri, P.; Orsenigo, M.; Caramuta, S.; Dagrada, G.; Losa, M.; Licitra, L.; Bossi, P.; Staurengo, S.; Oggionni, M.; Locati, L.; Cantu, G.; Squadrelli, M.; Carbone, A.; Pierotti, M. A.; Pilotti, S.
Advances in the changing patterns of aetiology of head and neck cancers
2006-01-01 Licitra, L.; Rossini, C.; Bossi, P.; Locati, L. D.
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new?
2006-01-01 Licitra, L.; Bossi, P.; Locati, L. D.
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients
2007-01-01 Bossi, P; Liberatoscioli, C; Bergamini, C; Locati, Ld; Fava, S; Rinaldi, G; Orlandi, E; Olmi, P; Tagliabue, E; Menard, S; Licitra, L
T-cell therapy for the control of EBV-related nasopharyngeal carcinoma
2007-01-01 Secondino, S; Basso, S; Pedrazzoli, P; Bossi, P; Labirio, M; Basilico, V; Locati, L; Schiavetto, I; Maccario, R; Licitra, L; Locatelli, F; Siena, S; Comoli, P
Optimizing the treatment of nasopharyngeal cancer: Anupdate of the milan experience including imrt and chemotherapy intensification
2007-01-01 Palazzi, M; Tomatis, S; Orlandi, E; Bossi, P; Guzzo, M; Potepan, P; Pignoli, E; Bergamini, C; Licitra, L; Scaramellini, G; Cantu, G; Olmi, P
New insights in chemotherapy
2007-01-01 Licitra, L; Locati, Ld; Bossi, P
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC)
2007-01-01 Bergamini, C; Bossi, P; Orlandi, E; Locati, L; Liberatoscioli, C; Fallai, C; Palazzi, M; Olmi, P; Licitra, L
Relationship between parotid glands dose and salivary toxicity in patients receiving intensity modulated radiation therapy (IMRT) and chemotherapy for nasopharyngeal carcinoma: Preliminary results
2007-01-01 Orlandi, E; Pignoli, E; Palazzi, M; Zonca, G; Tomatis, S; Sangalli, C; Bossi, P; Bergamini, C; Locati, Ld; Licitra, L; Olmi, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma | 1-gen-2003 | Sanguineti, G.; Bossi, P.; Pou, A.; Licitra, L. | |
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] | 1-gen-2003 | Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L. | |
Head and neck cancer | 1-gen-2004 | Licitra, L.; Locati, L. D.; Bossi, P. | |
Head and neck tumors other than squamous cell carcinoma | 1-gen-2004 | Licitra, L.; Locati, L. D.; Bossi, P.; Cantu, G. | |
Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy | 1-gen-2004 | Palazzi, M.; Guzzo, M.; Bossi, P.; Tomatis, S.; Cerrotta, A.; Cantu, G.; Locati, L. D.; Licitra, L. | |
Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma | 1-gen-2004 | Licitra, L.; Suardi, S.; Bossi, P.; Locati, L. D.; Mariani, L.; Quattrone, P.; Lo Vullo, S.; Oggionni, M.; Olmi, P.; Cantu, G.; Pierotti, M. A.; Pilotti, S. | |
Herceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancer [1] | 1-gen-2005 | Locati, L. D.; Rinaldi, G.; Bossi, P.; Dagrada, G. P.; Quattrone, P.; Cantu, G.; Licitra, L. | |
Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas? | 1-gen-2005 | Bergamini, C.; Barisella, M.; Locati, L. D.; Bossi, P.; Potepan, P.; Rinaldi, G.; Licitra, L. | |
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15] | 1-gen-2005 | Licitra, L.; Bossi, P.; Locati, L. D.; Bergamini, C. | |
Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland | 1-gen-2005 | Locati, L. D.; Guzzo, M.; Bossi, P.; Massone, P. P. B.; Conti, B.; Fumagalli, E.; Bareggi, C.; Cantu, G.; Licitra, L. | |
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma | 1-gen-2006 | Licitra, L; Perrone, F; Bossi, P; Suardi, S; Mariani, L; Artusi, R; Oggionni, M; Rossini, C; Cantu, G; Squadrelli, M; Quattrone, P; Locati, Ld; Bergamini, C; Olmi, P; Pierotti, Ma; Pilotti, S | |
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma | 1-gen-2006 | Perrone, F.; Suardi, S.; Pastore, E.; Casieri, P.; Orsenigo, M.; Caramuta, S.; Dagrada, G.; Losa, M.; Licitra, L.; Bossi, P.; Staurengo, S.; Oggionni, M.; Locati, L.; Cantu, G.; Squadrelli, M.; Carbone, A.; Pierotti, M. A.; Pilotti, S. | |
Advances in the changing patterns of aetiology of head and neck cancers | 1-gen-2006 | Licitra, L.; Rossini, C.; Bossi, P.; Locati, L. D. | |
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? | 1-gen-2006 | Licitra, L.; Bossi, P.; Locati, L. D. | |
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients | 1-gen-2007 | Bossi, P; Liberatoscioli, C; Bergamini, C; Locati, Ld; Fava, S; Rinaldi, G; Orlandi, E; Olmi, P; Tagliabue, E; Menard, S; Licitra, L | |
T-cell therapy for the control of EBV-related nasopharyngeal carcinoma | 1-gen-2007 | Secondino, S; Basso, S; Pedrazzoli, P; Bossi, P; Labirio, M; Basilico, V; Locati, L; Schiavetto, I; Maccario, R; Licitra, L; Locatelli, F; Siena, S; Comoli, P | |
Optimizing the treatment of nasopharyngeal cancer: Anupdate of the milan experience including imrt and chemotherapy intensification | 1-gen-2007 | Palazzi, M; Tomatis, S; Orlandi, E; Bossi, P; Guzzo, M; Potepan, P; Pignoli, E; Bergamini, C; Licitra, L; Scaramellini, G; Cantu, G; Olmi, P | |
New insights in chemotherapy | 1-gen-2007 | Licitra, L; Locati, Ld; Bossi, P | |
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC) | 1-gen-2007 | Bergamini, C; Bossi, P; Orlandi, E; Locati, L; Liberatoscioli, C; Fallai, C; Palazzi, M; Olmi, P; Licitra, L | |
Relationship between parotid glands dose and salivary toxicity in patients receiving intensity modulated radiation therapy (IMRT) and chemotherapy for nasopharyngeal carcinoma: Preliminary results | 1-gen-2007 | Orlandi, E; Pignoli, E; Palazzi, M; Zonca, G; Tomatis, S; Sangalli, C; Bossi, P; Bergamini, C; Locati, Ld; Licitra, L; Olmi, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile